Click here to view online. Add this email to your safelist.
AstraZeneca announces three large-scale initiatives in China to advance global medicine research and development
6 November 2019
AstraZeneca today announced three large-scale initiatives to build on the Company’s long-standing commitment to China and advance global research and development (R&D) for innovative new medicines.
|
|||||
|
|||||
|
For more information please visit astrazeneca.com. If you would like to unsubscribe please click here. |
